Company Filing History:
Years Active: 2007
Title: Frauke Schimmöoller: Innovator in Alzheimer's Research
Introduction
Frauke Schimmöoller is a notable inventor based in Menlo Park, CA. She has made significant contributions to the field of neuroscience, particularly in the study of Alzheimer's disease. Her innovative work focuses on the modulation of amyloid-beta production, which is crucial in understanding and potentially treating this debilitating condition.
Latest Patents
Frauke Schimmöoller holds a patent titled "Inhibition of Aβ production by β-secretase BACE2." This invention is based on the discovery that BACE2, a homolog of β-secretase BACE, can stimulate the processing of APP in a non-amyloidogenic pathway. This process effectively suppresses the level of Aβ. The patent provides methods and means for identifying and utilizing modulators of BACE2's unique activity to reduce Aβ production. The compounds identified through these methods may serve as potential candidates for treating Alzheimer's disease and other neurological disorders by decreasing β-amyloid deposit formation.
Career Highlights
Frauke Schimmöoller is currently associated with Scios Inc., where she continues her research and development efforts. Her work has garnered attention for its potential impact on therapeutic strategies for Alzheimer's disease.
Collaborations
Some of her notable coworkers include Barbara Cordell and Yu-Wang Liu, who contribute to the collaborative efforts in advancing research in this critical area.
Conclusion
Frauke Schimmöoller is a pioneering inventor whose work in Alzheimer's research holds promise for future treatments. Her innovative approaches to modulating amyloid-beta production are vital in the ongoing fight against neurological diseases.